{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-031995","form_type":"8-K","ticker":"TKNO","cik":"0001850902","company_name":"Alpha Teknova, Inc.","filed_at":"2025-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.299428+00:00","generated_at":"2026-05-25T15:29:57.292861+00:00","sec_items":["1.01","2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"confidence":"high","headline":"Teknova reports FY2024 revenue $37.7M (+3% YoY), guides FY2025 $39-42M, amends credit facility","bullets":["FY2024 revenue $37.7M (+3% YoY); Q4 revenue $9.3M (+18% YoY). Clinical Solutions Q4 revenue $1.85M (+110% YoY).","Net loss FY2024 $26.7M ($0.57/share) vs $36.8M ($1.16) in FY2023; adjusted EBITDA -$14.5M vs -$19.8M.","2025 guidance: revenue $39-42M, free cash outflow <$12M (vs -$13.5M in FY2024).","New $28.245M credit facility ($23.245M term + $5M revolver), maturity March 2030, principal pay starting April 2028.","Covenants: minimum net revenue $39M for TTM ending Dec 2025; minimum cash $8M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-031995","json":"https://secwatch.observer/filing/0000950170-25-031995.json","markdown":"https://secwatch.observer/filing/0000950170-25-031995.md","text":"https://secwatch.observer/filing/0000950170-25-031995.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850902/000095017025031995/0000950170-25-031995-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850902/000095017025031995/tkno-20250304.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T15:29:57.292861+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}